Author Correction: The preferences of people with amyotrophic lateral sclerosis on riluzole treatment in Europe

Affiliations

¹ Department of Neurology, German Center for Neurodegenerative Diseases (DZNE), University of Ulm, Ulm, Germany.
² Charles River Associates International, Zürich, Switzerland.
³ European Organization for Professionals and Patients With ALS (EUpALS), Leuven, Belgium.
⁴ Business Integration Partners S.p.A, Milan, Italy.
⁵ Zambon Biotech SPA, Bresso, Milan, Italy.
⁶ Sirius Scientific Consulting AG, 8852, Altendorf, Switzerland. hermann.russ@hotmail.de.
⁷ Department of Neuroscience and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy.
⁸ Department of Pathophysiology and Transplantation, Dino Ferrari Center, Università degli Studi di Milano, Milan, Italy.

Published Erratum

Albert C Ludolph et al. Sci Rep. 2025.

. 2025 May 1;15(1):15297.

doi: 10.1038/s41598-025-95009-7.

¹ Department of Neurology, German Center for Neurodegenerative Diseases (DZNE), University of Ulm, Ulm, Germany.
² Charles River Associates International, Zürich, Switzerland.
³ European Organization for Professionals and Patients With ALS (EUpALS), Leuven, Belgium.
⁴ Business Integration Partners S.p.A, Milan, Italy.
⁵ Zambon Biotech SPA, Bresso, Milan, Italy.
⁶ Sirius Scientific Consulting AG, 8852, Altendorf, Switzerland. hermann.russ@hotmail.de.
⁷ Department of Neuroscience and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy.
⁸ Department of Pathophysiology and Transplantation, Dino Ferrari Center, Università degli Studi di Milano, Milan, Italy.

No abstract available

Erratum for

The preferences of people with amyotrophic lateral sclerosis on riluzole treatment in Europe.
Ludolph AC, Grandjean H, Reviers E, De Micheli V, Bianchi C, Cardosi L, Russ H, Silani V. Ludolph AC, et al. Sci Rep. 2023 Dec 15;13(1):22497. doi: 10.1038/s41598-023-49424-3. Sci Rep. 2023. PMID: 38110502 Free PMC article.